https://www.selleckchem.com/products/ml348.html
essed by OCT on absorption process and coronary lumen dimension after Magmaris implantation. The authors analyzed 22 patients from the BIOSOLVE-II trial who underwent optical coherence tomography assessment immediately after receiving a Magmaris second-generation drug-eluting resorbable magnesium scaffold. The analysis found that after Magmaris implantation, the presence of higher endothelial shear stress (ESS) might be associated with slower strut absorption process but less luminal loss. This study is the first demonstrating the impact
Like
Comment
Share
